Relationship between response to lusutrombopag and splenic volume
Haruki Uojima(National Center for Global Health and Medicine), Wasaburo Koizumi(Kitasato University), Kôji Miyazaki(Saga Medical School Hospital), Makoto Kako(Shonan Kamakura General Hospital), Yoshitaka Arase(Tokai University), Katsuhiko Iwakiri(Nippon Medical School), Ryouichi Horie(Kanagawa Institute of Technology), Norio Itokawa(Chiba Hokusou Hospital), Takashi Satoh(Hokkaido University), Tatehiro Kagawa(Tokai University), Masanori Atsukawa(Nippon Medical School), Ji Hyun Sung(The University of Osaka), Kota Tsuruya(Tokai University), Hisashi Hidaka(Kitasato University)
Cited by 25
Related Papers
Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells.
|Journal of Biological Chemistry|1990|1.5k
KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.
|Journal of Biological Chemistry|1990|625
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.
|Proceedings of the National Academy of Sciences|1981|586
Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase.
|Journal of Biological Chemistry|1987|513
MAPKAP kinase‐2; a novel protein kinase activated by mitogen‐activated protein kinase.
|The EMBO Journal|1992|481